Qube Research & Technologies (QRT)
LGND icon

Qube Research & Technologies (QRT)’s Ligand Pharmaceuticals LGND Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.52M Buy
47,659
+32,266
+210% +$6.38M 0.01% 1306
2025
Q4 		$2.91M Buy
15,393
+11,761
+324% +$2.26M ﹤0.01% 2066
2025
Q3 		$643K Sell
3,632
-14,453
-80% -$2.15M ﹤0.01% 2648
2025
Q2 		$2.06M Buy
18,085
+13,035
+258% +$1.39M ﹤0.01% 2183
2025
Q1 		$531K Buy
+5,050
New +$571K ﹤0.01% 2523
2024
Q2 		– Sell
-79
Closed -$5.78K – 4342
2024
Q1 		$5.78K Sell
79
-14,580
-99% -$1.07M ﹤0.01% 3872
2023
Q4 		$1.05M Sell
14,659
-25,595
-64% -$1.51M ﹤0.01% 1895
2023
Q3 		$2.41M Buy
40,254
+24,610
+157% +$1.62M 0.01% 1281
2023
Q2 		$1.13M Buy
15,644
+10,396
+198% +$780K ﹤0.01% 1257
2023
Q1 		$386K Buy
5,248
+1,481
+39% +$105K ﹤0.01% 1654
2022
Q4 		$252K Sell
3,767
-9,092
-71% -$591K ﹤0.01% 1715
2022
Q3 		$691K Sell
12,859
-20,597
-62% -$1.21M ﹤0.01% 1339
2022
Q2 		$1.86M Buy
33,456
+21,499
+180% +$1.22M 0.01% 849
2022
Q1 		$839K Buy
+11,957
New +$868K 0.01% 1255
2020
Q3 		– Sell
-24,795
Closed -$1.73M – 1933
2020
Q2 		$1.73M Buy
+24,795
New +$1.57M 0.03% 698

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LGND Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Ligand Pharmaceuticals (LGND) stake by 210% in Q1 2026, buying an estimated $6.38M and bringing the position to 47,659 shares worth $9.52M. The position accounts for 0.01% of the portfolio, ranked #1306.

Qube Research & Technologies (QRT) first reported a position in LGND in Q2 2020 and has held it in 15 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Qube Research & Technologies (QRT) held 47,659 shares of Ligand Pharmaceuticals worth $9.52M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 32,266 Ligand Pharmaceuticals shares in Q1 2026, an estimated $6.38M.
  • Ligand Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1306 holding.
  • Qube Research & Technologies (QRT) first reported a position in Ligand Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.